The FDA has approved expanded MRI labeling for Abbott’s Eterna spinal cord stimulation system, allowing those with chronic pain to undergo MRI within specific conditions and have a wider selection of lead options for full-body scans.According to an Abbott press release, people with spinal cord stimulation systems often require MRI to evaluate disease progression of conditions such as cancer
The US Food and Drug Administration has approved the Proclaim Plus spinal cord stimulation system with FlexBurst360 therapy, which provides personalized coverage at up to six pain points.